| Literature DB >> 27865310 |
Crystal L Ramanujam1, Thomas Zgonis2.
Abstract
Knowledge of diabetic Charcot neuroarthropathy (DCN) has grown tremendously since this condition was first described in 1936 by William Riely Jordan. Despite advancements in diagnostic approaches and treatment options making DCN limb salvage a more viable option, ongoing and additional research is needed to determine the definitive pathogenesis, which may aid in prevention of the condition. This article chronicles the main developments for the study and management of DCN since 1936 and recommends using the term diabetic Charcot-Jordan foot when specifically managing foot and ankle neuroarthropathy joints in patients with diabetic neuropathy.Entities:
Keywords: Charcot classification; Charcot neuroarthropathy; Diabetes mellitus; Diabetic Charcot foot; Diabetic Charcot-Jordan Foot; Diabetic neuropathy
Mesh:
Year: 2016 PMID: 27865310 DOI: 10.1016/j.cpm.2016.07.001
Source DB: PubMed Journal: Clin Podiatr Med Surg ISSN: 0891-8422 Impact factor: 1.231